Interestingly, an additional study discovered a rs11672691-mediated promoter-enhancer switching mechanism driving the expression of lncRNA PCAT19 and thus the initiation and progression of aggressive prostate cancer [72]. Here, PCAT19 is linked to prostate carcinoma.